Galanan, Lelebeth L.
HRN: 14-89-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
CEFUROXIME 1.5GM (VIAL)
08/15/2022
08/22/2022
IVT
1.5g
Q8
S/P LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes Wrong Duration
Overall appropriateness: Yes